The outcome of physical symptoms with treatment of depression

Journal of General Internal Medicine

Volumn 19, Issue 8, 2004, Pages 813-818

  Greco, Teri ^a   Eckert, George ^a   Kroenke, Kurt ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

Author keywords

Antidepressants; Depression; Physical symptoms; Selective serotonin reuptake inhibitors; Somatization

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; BACKACHE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DIZZINESS; DYSPNEA; FATIGUE; FEMALE; HEADACHE; HEALTH STATUS; HEART PALPITATION; HUMAN; INDIGESTION; INTERVIEW; LIMB PAIN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MENTAL FUNCTION; NAUSEA; PERCEPTION; PHYSICAL DISEASE; PHYSICIAN; PREVALENCE; PRIMARY MEDICAL CARE; QUALITY OF LIFE; RANDOMIZATION; RANDOMIZED CONTROLLED TRIAL; SLEEP DISORDER; SOCIAL STATUS; STOMACH PAIN; SYMPTOM; SYNCOPE; THORAX PAIN; TREATMENT OUTCOME;

DEPRESSIVE DISORDER; FEMALE; FLUOXETINE; FOLLOW-UP STUDIES; HEALTH STATUS; HEALTH SURVEYS; HUMANS; MALE; MIDDLE AGED; PAROXETINE; QUALITY OF LIFE; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; SOMATOFORM DISORDERS; TREATMENT OUTCOME;

EID: 4143093857     PISSN: 08848734     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1525-1497.2004.30531.x     Document Type: Article

References (37)

1. Kroenke K. Spitzer RL, Williams JB, et al. Physical symptoms in primary care: predictors of psychiatric disorders and functional impairment. Arch Fam Med. 1994;3:774-9.
2. Katon W, Kleinman A, Rosen G. Depression and somatization: a review. Part I. Am J Med. 1982;72:127-35.
3. Katon W, Kleinman A, Rosen G. Depression and somatization: a review. Part II. Am J Med. 1982;72:241-7.
4. Kroenke K, Jackson JL, Chamberlm J. Depressive and anxiety disorders in patients presenting with physical complaints: clinical predictors and outcome. Am J Med. 1997;103:339-47.
5. Kroenke K. Patients presenting with somatic complaints: epidemiology, psychiatric comorbidity and management. Int J Methods Psychiatr Res. 2003;12:34-43.
6. Sullivan M, Katon W. Somatization. APS J. 1993;3:141-59.
7. Mathew RJ, Weinman ML, Mirabi M. Physical symptoms of depression. Br J Psychiatry. 1981;139:293-6.
8. Simon G, VonKorff M. Somatization and psychiatric disorder in the NIMH Epidemiologic Catchment Area Study. Am J Psychiatry. 1991;11:1494-500.
9. Katon W, Sullivan M, Walker E. Medical symptoms without identified pathology: relationship to psychiatric disorders, childhood and adult trauma, and personality traits. Ann Intern Med. 2001;134:917-25.
10. Kirmayer LJ, Robbins JM, Dworkind M, Yaffe MJ. Somatization and the recognition of depression and anxiety in primary care. Am J Psychiatry. 1993;5:734-41.
11. Bridges KW, Goldberg DP. Somatic presentations of DSM III psychiatric disorders in primary care. J Psychosom Res. 1985;29:563-9.
12. Kirmayer L, Robbins J. Patients who somatize in primary care: a longitudinal study of cognitive and social characteristics. Psychol Med. 1996;26:937-51.
13. Simon G, VonKorff M, Piccinelli M, Fullerton C, Omel J. An international study of the relation between somatic symptoms and depression. N Engl J Med. 1999;341:1329-35.
14. Kroenke K, Jackson JL. Outcomes in general medical patients presenting with common symptoms: a prospective study with a 2-week and a 3-month follow-up. Fam Pract. 1998;5:398-403.
15. Kroenke K, West SL, Swindle R, et al. Similar effects of paroxetine. fluoxetine, and sertraline in primary care: a randomized trial. JAMA. 2001;286:2947-55.
16. Simon GE, Revicki D, VonKorff M. Telephone assessment of depression severity. J Psychiatr Res. 1993;27:247-52.
17. Katon W, Robinson P, VonKorff M, et al. A multifaceted intervention to improve treatment of depression in primary care. Arch Gen Psychiatry. 1996;53:924-32.
18. Unützer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836-45.
19. Spitzer RL, Kroenke K, Williams JBW. Patient Health Questionnaire Study Group. Validity and utility of a self-report version of PRIME-MD. JAMA. 1999;282:1737-44.
20. Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606-13.
21. Kroenke K, Spitzer RL, Williams JB. The PHQ-15: validity of a new measure for evaluating the severity of somatic symptoms. Psychosom Med. 2002;64:258-66.
22. Ware JE. SF-36 Health Survey: Manual and Interpretation Guide. Boston, Mass: The Health Institute, New England Medical Center; 1993.
23. Ware JE, Gandek B. The SF-36 Health Survey: development and use in mental health research and the IQOLA project. Int J Ment Health. 1994;23:49-73.
24. Lerner D, Amick B III, Glaxo Wellcome, Inc. Work Limitations Questionnaire. Boston, Mass: The Health Institute, New England Medical Center; 1998.
25. Stewart AL, Ware JE. Measuring Functioning and Well-Being: The Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
26. Spitzer RL, Williams JBW, Kroenke K, et al. Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749-56.
27. Moos RH, Cronkite RC, Finney JW. Health and Daily Living Form Manual. Palo Alto, Calif: Mind Garden; 1990.
28. VonKorff M, Wagner EH, Saunders K. A chronic disease score from automated pharmacy data. J Clin Epidemiol. 1992;45:197-203.
29. Clark DO, Von Korff M, Saunders K, et al. A chronic disease score with empirically derived weights. Med Care. 1995;33:783-95.
30. Unutzer J, Katon W, Callahan CM, et al. Collaborative care management of late-life depression in the primary care setting: a randomized controlled trial. JAMA. 2002;288:2836-45.
31. Widmer RB, Cadoret RJ. Depression in primary care: changes in pattern of patient visits and complaints during a developing depression. J Fam Pract. 1978;7:293-302.
32. Widmer RB, Cadoret RJ. Depression in family practice: changes in pattern of patient visits and complaints during subsequent developing depressions. J Fam Pract. 1979;9:1017-21.
33. Bair MJ, Robinson RL, Katon W, Kroenke K. Exploring depression and pain comorbidity: a literature review. Arch Intern Med. 2003;163:2433-45.
34. Bair MJ, Robinson RL, Eckert GJ, Stang PE, Crogan TW, Kroenke K. Impact of pain on depression treatment response in primary care. Psychosom Med. 2002;66:17-22.
35. O'Malley PG, Jackson JL, Tomkins G, Santoro J, Balden E, Kroenke K. Antidepressant therapy for unexplained symptoms and symptom syndromes: a critical review. J Fam Pract. 1999;48:980-93.
36. Kroenke K, Swindle R. Cognitive-behavioral therapy for somatization and symptom syndromes: a critical review of clinical trials. Psychother Psychosom. 2000;69:205-15.
37. Allen LA, Escobar JI, Lehrer PM, Gara M, Woolfolk RL. Psychosocial treatments for multiple unexplained physical symptoms: a review of literature. Psychosom Med. 2002;64:939-50.